Table of Contents Global Migraine Therapeutics Market Research Report 2020, Forecast to 2025 1 Market Overview 1.1 Migraine Therapeutics Definition 1.1.1 Analysis of Macroeconomic Indicators 1.1.2 Years Considered 1.2 Migraine Therapeutics Segment by Type 1.2.1 Specific Anti-migraine Drugs 1.2.2 Acute Therapies 1.2.3 Preventative Therapies 1.2.4 Other 1.3 Market Analysis by Application 1.3.1 Hospitals 1.3.2 Clinics 1.3.3 Household Use 1.3.4 Others 1.4 Overview of Global Migraine Therapeutics Market 1.4.1 Global Migraine Therapeutics Revenue (2015-2025) 1.4.2 Global Migraine Therapeutics Production and Capacity (2015-2025) 1.4.3 North America Migraine Therapeutics Status and Prospect (2015-2025) 1.4.4 Europe Migraine Therapeutics Status and Prospect (2015-2025) 1.4.5 Japan Migraine Therapeutics Status and Prospect (2014-2025) 1.4.6 China Migraine Therapeutics Status and Prospect (2015-2025) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 1.5.4 Porter's Five Forces Analysis 1.5.5 SWOT Analysis 1.6 Coronavirus Disease 2019 (Covid-19): Migraine Therapeutics Industry Impact 1.6.1 How the Covid-19 is Affecting the Migraine Therapeutics Industry 1.6.2 Migraine Therapeutics Business Impact Assessment - Covid-19 1.6.3 Market Trends and Migraine Therapeutics Potential Opportunities in the COVID-19 Landscape 1.6.4 Measures / Proposal against Covid-19 2 Global Migraine Therapeutics Market Competition by Manufacturer 2.1 Global Migraine Therapeutics Sales and Market Share by Manufacturer (2018-2020) 2.2 Global Migraine Therapeutics Revenue and Market Share by Manufacturer (2018-2020) 2.3 Global Migraine Therapeutics Industry Concentration Ratio (CR5 and HHI) 2.4 Top 5 Migraine Therapeutics Manufacturer Market Share 2.5 Top 10 Migraine Therapeutics Manufacturer Market Share 2.6 Date of Key Manufacturers Enter into Migraine Therapeutics Market 2.7 Key Manufacturers Migraine Therapeutics Product Offered 2.8 Mergers & Acquisitions Planning 3 Analysis of Migraine Therapeutics Industry Key Manufacturers 3.1 Allergan 3.1.1 Company Details 3.1.2 Product Information 3.1.3 Allergan Migraine Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.1.4 Main Business Overview 3.1.5 Allergan News 3.2 Merck 3.2.1 Company Details 3.2.2 Product Information 3.2.3 Merck Migraine Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.2.4 Main Business Overview 3.2.5 Merck News 3.3 Pfizer 3.3.1 Company Details 3.3.2 Product Information 3.3.3 Pfizer Migraine Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.3.4 Main Business Overview 3.3.5 Pfizer News 3.4 Teva 3.4.1 Company Details 3.4.2 Product Information 3.4.3 Teva Migraine Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.4.4 Main Business Overview 3.4.5 Teva News 3.5 Amgen 3.5.1 Company Details 3.5.2 Product Information 3.5.3 Amgen Migraine Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.5.4 Main Business Overview 3.5.5 Amgen News 3.6 Johnson & Johnson 3.6.1 Company Details 3.6.2 Product Information 3.6.3 Johnson & Johnson Migraine Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.6.4 Main Business Overview 3.6.5 Johnson & Johnson News 3.7 Endo International 3.7.1 Company Details 3.7.2 Product Information 3.7.3 Endo International Migraine Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.7.4 Main Business Overview 3.7.5 Endo International News 3.8 GlaxoSmithKline 3.8.1 Company Details 3.8.2 Product Information 3.8.3 GlaxoSmithKline Migraine Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.8.4 Main Business Overview 3.8.5 GlaxoSmithKline News 3.9 Impax 3.9.1 Company Details 3.9.2 Product Information 3.9.3 Impax Migraine Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.9.4 Main Business Overview 3.9.5 Impax News 3.10 Abbott 3.10.1 Company Details 3.10.2 Product Information 3.10.3 Abbott Migraine Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.10.4 Main Business Overview 3.10.5 Abbott News 3.11 Bayer 3.11.1 Company Details 3.11.2 Product Information 3.11.3 Bayer Migraine Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.11.4 Main Business Overview 3.11.5 Bayer News 3.12 Eli Lilly 3.12.1 Company Details 3.12.2 Product Information 3.12.3 Eli Lilly Migraine Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.12.4 Main Business Overview 3.12.5 Eli Lilly News 3.13 Novartis International 3.13.1 Company Details 3.13.2 Product Information 3.13.3 Novartis International Migraine Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.13.4 Main Business Overview 3.13.5 Novartis International News 3.14 Ethypharm 3.14.1 Company Details 3.14.2 Product Information 3.14.3 Ethypharm Migraine Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.14.4 Main Business Overview 3.14.5 Ethypharm News 3.15 Kowa Pharmaceuticals America 3.15.1 Company Details 3.15.2 Product Information 3.15.3 Kowa Pharmaceuticals America Migraine Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.15.4 Main Business Overview 3.15.5 Kowa Pharmaceuticals America News 3.16 Winston Pharmaceuticals 3.16.1 Company Details 3.16.2 Product Information 3.16.3 Winston Pharmaceuticals Migraine Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.16.4 Main Business Overview 3.16.5 Winston Pharmaceuticals News 3.17 AstraZeneca 3.17.1 Company Details 3.17.2 Product Information 3.17.3 AstraZeneca Migraine Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.17.4 Main Business Overview 3.17.5 AstraZeneca News 3.18 Amirall 3.18.1 Company Details 3.18.2 Product Information 3.18.3 Amirall Migraine Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.18.4 Main Business Overview 3.18.5 Amirall News 3.19 OptiNose 3.19.1 Company Details 3.19.2 Product Information 3.19.3 OptiNose Migraine Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.19.4 Main Business Overview 3.19.5 OptiNose News 3.20 Revance Therapeutics 3.20.1 Company Details 3.20.2 Product Information 3.20.3 Revance Therapeutics Migraine Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.20.4 Main Business Overview 3.20.5 Revance Therapeutics News 3.21 RedHill Biopharma 3.21.1 Company Details 3.21.2 Product Information 3.21.3 RedHill Biopharma Migraine Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.21.4 Main Business Overview 3.21.5 RedHill Biopharma News 3.22 Bausch Health 3.22.1 Company Details 3.22.2 Product Information 3.22.3 Bausch Health Migraine Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.22.4 Main Business Overview 3.22.5 Bausch Health News 3.23 NeurAxon 3.23.1 Company Details 3.23.2 Product Information 3.23.3 NeurAxon Migraine Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.23.4 Main Business Overview 3.23.5 NeurAxon News 3.24 Biohaven Pharma 3.24.1 Company Details 3.24.2 Product Information 3.24.3 Biohaven Pharma Migraine Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.24.4 Main Business Overview 3.24.5 Biohaven Pharma News 3.25 Eisai 3.25.1 Company Details 3.25.2 Product Information 3.25.3 Eisai Migraine Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.25.4 Main Business Overview 3.25.5 Eisai News 3.26 Valeant Pharma 3.26.1 Company Details 3.26.2 Product Information 3.26.3 Valeant Pharma Migraine Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.26.4 Main Business Overview 3.26.5 Valeant Pharma News 4 Global Migraine Therapeutics Market Size Categorized by Regions (2015-2020) 4.1 Global Migraine Therapeutics Sales Market Share by Region 4.2 Global Migraine Therapeutics Revenue Market Share by Region (2015-2019) 4.3 Global Migraine Therapeutics Sales, Revenue, Price and Gross Margin (2015-2020) 4.4 North America Migraine Therapeutics Market Size Detail 4.4.1 North America Migraine Therapeutics Sales Growth Rate (2015-2020) 4.4.2 North America Migraine Therapeutics Sales, Revenue, Price and Gross Margin (2015-2020) 4.5 Europe Migraine Therapeutics Market Size Detail 4.5.1 Europe Migraine Therapeutics Sales Growth Rate (2015-2020) 4.5.2 Europe Migraine Therapeutics Sales, Revenue, Price and Gross Margin (2015-2020) 4.6 Japan Migraine Therapeutics Market Size Detail 4.6.1 Japan Migraine Therapeutics Sales Growth Rate (2015-2020) 4.6.2 Japan Migraine Therapeutics Sales, Revenue, Price and Gross Margin (2015-2020) 4.7 China Migraine Therapeutics Market Size Detail 4.7.1 China Migraine Therapeutics Sales Growth Rate (2015-2020) 4.7.2 China Migraine Therapeutics Sales, Revenue, Price and Gross Margin (2015-2020) 5 Global Migraine Therapeutics Market Segment by Type 5.1 Global Migraine Therapeutics Revenue, Sales and Market Share by Type (2015-2020) 5.1.1 Global Migraine Therapeutics Sales and Market Share by Type (2015-2020) 5.1.2 Global Migraine Therapeutics Revenue and Market Share by Type (2015-2020) 5.2 Specific Anti-migraine Drugs Sales Growth Rate and Price 5.2.1 Global Specific Anti-migraine Drugs Sales Growth Rate (2015-2020) 5.2.2 Global Specific Anti-migraine Drugs Price (2015-2020) 5.3 Acute Therapies Sales Growth Rate and Price 5.3.1 Global Acute Therapies Sales Growth Rate (2015-2020) 5.3.2 Global Acute Therapies Price (2015-2020) 5.4 Preventative Therapies Sales Growth Rate and Price 5.4.1 Global Preventative Therapies Sales Growth Rate (2015-2020) 5.4.2 Global Preventative Therapies Price (2015-2020) 5.5 Other Sales Growth Rate and Price 5.5.1 Global Other Sales Growth Rate (2015-2020) 5.5.2 Global Other Price (2015-2020) 6 Global Migraine Therapeutics Market Segment by Application 6.1 Global Migraine Therapeutics Sales Market Share by Application (2015-2020) 6.2 Hospitals Sales Growth Rate (2015-2020) 6.3 Clinics Sales Growth Rate (2015-2020) 6.4 Household Use Sales Growth Rate (2015-2020) 6.5 Others Sales Growth Rate (2015-2020) 7 Migraine Therapeutics Related Market Analysis 7.1 Upstream Analysis 7.1.1 Macro Analysis of Upstream Markets 7.1.2 Key Players in Upstream Markets 7.1.3 Upstream Market Trend Analysis 7.1.4 Migraine Therapeutics Manufacturing Cost Analysis 7.2 Downstream Market Analysis 7.2.1 Macro Analysis of Down Markets 7.2.2 Key Players in Down Markets 7.2.3 Downstream Market Trend Analysis 7.2.4 Sales Channel, Distributors, Traders and Dealers 8 Global Migraine Therapeutics Market Forecast 8.1 Global Migraine Therapeutics Sales, Revenue Forecast 8.1.1 Global Migraine Therapeutics Sales Growth Rate Forecast (2020-2025) 8.1.2 Global Migraine Therapeutics Revenue and Growth Rate Forecast (2020-2025) 8.1.3 Global Migraine Therapeutics Price and Trend Forecast (2020-2025) 8.2 Global Migraine Therapeutics Sales Forecast by Region (2020-2025) 8.2.1 North America Migraine Therapeutics Sales, Revenue Forecast (2020-2025) 8.2.2 Europe Migraine Therapeutics Sales, Revenue Forecast (2020-2025) 8.2.3 Japan Migraine Therapeutics Production, Revenue Forecast (2020-2025) 8.2.4 China Migraine Therapeutics Production, Revenue Forecast (2020-2025) 9 Research Findings and Conclusion 10 Appendix

List of Tables and Figures Figure Migraine Therapeutics Picture Table Global Migraine Therapeutics Sales by Type Figure Global Sales Market Share of Migraine Therapeutics by Product Type in 2019 Table Breakdown of Migraine Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3) Figure Migraine Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) Figure Specific Anti-migraine Drugs Picture Figure Acute Therapies Picture Figure Preventative Therapies Picture Figure Other Picture Table Global Migraine Therapeutics Sales by Application Figure Global Migraine Therapeutics Sales Market Share by Application in 2019 Figure Hospitals Picture Figure Clinics Picture Figure Household Use Picture Figure Others Picture Table Migraine Therapeutics Market Size Comparison by Region (2019-2025) (K Units) & (Million US$) Figure Global Migraine Therapeutics Revenue (Million US$) (2015-2025) Figure Global Migraine Therapeutics Production (K Units) (2015-2025) Figure North America Migraine Therapeutics Revenue (Million US$) Growth Rate (2015-2025) Figure Europe Migraine Therapeutics Revenue (Million US$) Growth Rate (2015-2025) Figure Japan Migraine Therapeutics Revenue (Million US$) Growth Rate (2014-2025) Figure China Migraine Therapeutics Revenue (Million US$) Growth Rate (2015-2025) Table Market Opportunities in Next Few Years Table Market Risks Analysis Table Market Drivers Figure Porter's Five Forces Analysis Table SWOT Analysis Table Global Migraine Therapeutics Sales by Manufacturer (2018-2020) Figure Global Migraine Therapeutics Sales Market Share by Manufacturer in 2019 Table Global Migraine Therapeutics Revenue by Manufacturer (2018-2020) Figure Global Migraine Therapeutics Revenue Market Share by Manufacturer in 2019 Table Global Migraine Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI) Figure Top 5 Migraine Therapeutics Manufacturer (Revenue) Market Share in 2019 Figure Top 10 Migraine Therapeutics Manufacturer (Revenue) Market Share in 2019 Table Date of Key Manufacturers Enter into Migraine Therapeutics Market Table Key Manufacturers Migraine Therapeutics Product Type Table Mergers & Acquisitions Planning Table Allergan Company Profile Figure Migraine Therapeutics Product Picture and Specifications of Allergan Table Migraine Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020 Figure Allergan Migraine Therapeutics Market Share (2018-2020) Table Allergan Main Business Table Allergan Recent Development Table Merck Company Profile Figure Migraine Therapeutics Product Picture and Specifications of Merck Table Migraine Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020 Figure Merck Migraine Therapeutics Market Share (2018-2020) Table Merck Main Business Table Merck Recent Development Table Pfizer Company Profile Figure Migraine Therapeutics Product Picture and Specifications of Pfizer Table Migraine Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020 Figure Pfizer Migraine Therapeutics Market Share (2018-2020) Table Pfizer Main Business Table Pfizer Recent Development Table Teva Company Profile Figure Migraine Therapeutics Product Picture and Specifications of Teva Table Migraine Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020 Figure Teva Migraine Therapeutics Market Share (2018-2020) Table Teva Main Business Table Teva Recent Development Table Amgen Company Profile Figure Migraine Therapeutics Product Picture and Specifications of Amgen Table Migraine Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020 Figure Amgen Migraine Therapeutics Market Share (2018-2020) Table Amgen Main Business Table Amgen Recent Development Table Johnson & Johnson Company Profile Figure Migraine Therapeutics Product Picture and Specifications of Johnson & Johnson Table Migraine Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020 Figure Johnson & Johnson Migraine Therapeutics Market Share (2018-2020) Table Johnson & Johnson Main Business Table Johnson & Johnson Recent Development Table Endo International Company Profile Figure Migraine Therapeutics Product Picture and Specifications of Endo International Table Migraine Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020 Figure Endo International Migraine Therapeutics Market Share (2018-2020) Table Endo International Main Business Table Endo International Recent Development Table GlaxoSmithKline Company Profile Figure Migraine Therapeutics Product Picture and Specifications of GlaxoSmithKline Table Migraine Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020 Figure GlaxoSmithKline Migraine Therapeutics Market Share (2018-2020) Table GlaxoSmithKline Main Business Table GlaxoSmithKline Recent Development Table Impax Company Profile Figure Migraine Therapeutics Product Picture and Specifications of Impax Table Migraine Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020 Figure Impax Migraine Therapeutics Market Share (2018-2020) Table Impax Main Business Table Impax Recent Development Table Abbott Company Profile Figure Migraine Therapeutics Product Picture and Specifications of Abbott Table Migraine Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020 Figure Abbott Migraine Therapeutics Market Share (2018-2020) Table Abbott Main Business Table Abbott Recent Development Table Bayer Company Profile Figure Migraine Therapeutics Product Picture and Specifications of Bayer Table Migraine Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020 Figure Bayer Migraine Therapeutics Market Share (2018-2020) Table Bayer Main Business Table Bayer Recent Development Table Eli Lilly Company Profile Figure Migraine Therapeutics Product Picture and Specifications of Eli Lilly Table Migraine Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020 Figure Eli Lilly Migraine Therapeutics Market Share (2018-2020) Table Eli Lilly Main Business Table Eli Lilly Recent Development Table Novartis International Company Profile Figure Migraine Therapeutics Product Picture and Specifications of Novartis International Table Migraine Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020 Figure Novartis International Migraine Therapeutics Market Share (2018-2020) Table Novartis International Main Business Table Novartis International Recent Development Table Ethypharm Company Profile Figure Migraine Therapeutics Product Picture and Specifications of Ethypharm Table Migraine Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020 Figure Ethypharm Migraine Therapeutics Market Share (2018-2020) Table Ethypharm Main Business Table Ethypharm Recent Development Table Kowa Pharmaceuticals America Company Profile Figure Migraine Therapeutics Product Picture and Specifications of Kowa Pharmaceuticals America Table Migraine Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020 Figure Kowa Pharmaceuticals America Migraine Therapeutics Market Share (2018-2020) Table Kowa Pharmaceuticals America Main Business Table Kowa Pharmaceuticals America Recent Development Table Winston Pharmaceuticals Company Profile Figure Migraine Therapeutics Product Picture and Specifications of Winston Pharmaceuticals Table Migraine Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020 Figure Winston Pharmaceuticals Migraine Therapeutics Market Share (2018-2020) Table Winston Pharmaceuticals Main Business Table Winston Pharmaceuticals Recent Development Table AstraZeneca Company Profile Figure Migraine Therapeutics Product Picture and Specifications of AstraZeneca Table Migraine Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020 Figure AstraZeneca Migraine Therapeutics Market Share (2018-2020) Table AstraZeneca Main Business Table AstraZeneca Recent Development Table Amirall Company Profile Figure Migraine Therapeutics Product Picture and Specifications of Amirall Table Migraine Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020 Figure Amirall Migraine Therapeutics Market Share (2018-2020) Table Amirall Main Business Table Amirall Recent Development Table OptiNose Company Profile Figure Migraine Therapeutics Product Picture and Specifications of OptiNose Table Migraine Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020 Figure OptiNose Migraine Therapeutics Market Share (2018-2020) Table OptiNose Main Business Table OptiNose Recent Development Table Revance Therapeutics Company Profile Figure Migraine Therapeutics Product Picture and Specifications of Revance Therapeutics Table Migraine Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020 Figure Revance Therapeutics Migraine Therapeutics Market Share (2018-2020) Table Revance Therapeutics Main Business Table Revance Therapeutics Recent Development Table RedHill Biopharma Company Profile Figure Migraine Therapeutics Product Picture and Specifications of RedHill Biopharma Table Migraine Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020 Figure RedHill Biopharma Migraine Therapeutics Market Share (2018-2020) Table RedHill Biopharma Main Business Table RedHill Biopharma Recent Development Table Bausch Health Company Profile Figure Migraine Therapeutics Product Picture and Specifications of Bausch Health Table Migraine Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020 Figure Bausch Health Migraine Therapeutics Market Share (2018-2020) Table Bausch Health Main Business Table Bausch Health Recent Development Table NeurAxon Company Profile Figure Migraine Therapeutics Product Picture and Specifications of NeurAxon Table Migraine Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020 Figure NeurAxon Migraine Therapeutics Market Share (2018-2020) Table NeurAxon Main Business Table NeurAxon Recent Development Table Biohaven Pharma Company Profile Figure Migraine Therapeutics Product Picture and Specifications of Biohaven Pharma Table Migraine Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020 Figure Biohaven Pharma Migraine Therapeutics Market Share (2018-2020) Table Biohaven Pharma Main Business Table Biohaven Pharma Recent Development Table Eisai Company Profile Figure Migraine Therapeutics Product Picture and Specifications of Eisai Table Migraine Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020 Figure Eisai Migraine Therapeutics Market Share (2018-2020) Table Eisai Main Business Table Eisai Recent Development Table Valeant Pharma Company Profile Figure Migraine Therapeutics Product Picture and Specifications of Valeant Pharma Table Migraine Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020 Figure Valeant Pharma Migraine Therapeutics Market Share (2018-2020) Table Valeant Pharma Main Business Table Valeant Pharma Recent Development Table Global Migraine Therapeutics Sales (K Units) by Region (2015-2020) Table Global Migraine Therapeutics Sales Market Share by Region (2015-2019) Figure Global Migraine Therapeutics Sales Market Share by Region (2015-2019) Figure Global Migraine Therapeutics Sales Market Share by Region in 2018 Table Global Migraine Therapeutics Revenue (Million US$) by Region (2015-2020) Table Global Migraine Therapeutics Revenue Market Share by Region (2015-2020) Figure Global Migraine Therapeutics Revenue Market Share by Region (2015-2020) Figure Global Migraine Therapeutics Revenue Market Share by Region in 2019 Table Global Migraine Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure North America Migraine Therapeutics Sales (K Units) Growth Rate (2015-2020) Figure Europe Migraine Therapeutics Sales (K Units) Growth Rate (2015-2020) Table Europe Migraine Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure Japan Migraine Therapeutics Sales (K Units) Growth Rate (2015-2020) Table Japan Migraine Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure China Migraine Therapeutics Sales (K Units) Growth Rate (2015-2020) Table China Migraine Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table Global Migraine Therapeutics Sales by Type (2015-2020) Table Global Migraine Therapeutics Sales Market Share by Type (2015-2020) Figure Global Migraine Therapeutics Sales Market Share by Type in 2019 Table Global Migraine Therapeutics Revenue by Type (2015-2020) Table Global Migraine Therapeutics Revenue Market Share by Type (2015-2020) Figure Global Migraine Therapeutics Revenue Market Share by Type in 2019 Figure Global Specific Anti-migraine Drugs Sales Growth Rate (2015-2025) Figure Global Specific Anti-migraine Drugs Price (2015-2020) Figure Global Acute Therapies Sales Growth Rate (2015-2025) Figure Global Acute Therapies Price (2015-2020) Figure Global Preventative Therapies Sales Growth Rate (2015-2025) Figure Global Preventative Therapies Price (2015-2020) Figure Global Other Sales Growth Rate (2015-2025) Figure Global Other Price (2015-2020) Table Global Migraine Therapeutics Sales Market Share by Application (2015-2020) Figure Global Migraine Therapeutics Sales Market Share by Application in 2019 Figure Global Hospitals Sales Growth Rate (2015-2025) Figure Global Clinics Sales Growth Rate (2015-2025) Figure Global Household Use Sales Growth Rate (2015-2025) Figure Global Others Sales Growth Rate (2015-2025) Table Key Players of Upstream Markets Table Key Raw Materials Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Migraine Therapeutics Table Key Players of Downstream Markets Figure Sales Channel Figure Global Migraine Therapeutics Production (K Units) Growth Rate Forecast (2020-2025) Figure Global Migraine Therapeutics Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Global Migraine Therapeutics Price and Trend Forecast (2020-2025) Table Global Migraine Therapeutics Sales (K Units) Forecast by Region (2020-2025) Figure Global Migraine Therapeutics Production Market Share Forecast by Region (2020-2025) Figure North America Migraine Therapeutics Sales (K Units) Growth Rate Forecast (2020-2025) Figure North America Migraine Therapeutics Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Europe Migraine Therapeutics Sales (K Units) Growth Rate Forecast (2020-2025) Figure Europe Migraine Therapeutics Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Japan Migraine Therapeutics Production (K Units) Growth Rate Forecast (2020-2025) Figure Japan Migraine Therapeutics Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure China Migraine Therapeutics Production (K Units) Growth Rate Forecast (2020-2025) Figure China Migraine Therapeutics Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Methodology/Research Approach Figure Market Size Estimation Figure Author List

Allergan Merck Pfizer Teva Amgen Johnson & Johnson Endo International GlaxoSmithKline Impax Abbott Bayer Eli Lilly Novartis International Ethypharm Kowa Pharmaceuticals America Winston Pharmaceuticals AstraZeneca Amirall OptiNose Revance Therapeutics RedHill Biopharma Bausch Health NeurAxon Biohaven Pharma